Jensen Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$294M |
| 2 |
McDonald's
MCD
|
+$125M |
| 3 |
MRSH
Marsh
MRSH
|
+$47.2M |
| 4 |
MSCI
MSCI
|
+$3.45M |
| 5 |
ON Semiconductor
ON
|
+$2.38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$339M |
| 2 |
PepsiCo
PEP
|
+$289M |
| 3 |
Moody's
MCO
|
+$95.6M |
| 4 |
Microsoft
MSFT
|
+$95.2M |
| 5 |
Home Depot
HD
|
+$71.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.16% |
| 2 | Healthcare | 15.94% |
| 3 | Consumer Discretionary | 12.02% |
| 4 | Financials | 9.52% |
| 5 | Industrials | 8% |
Similar funds
Jensen Investment Management's Q1 2024 Portfolio in Review
As of Q1 2024, Jensen Investment Management held 86 positions worth $13.1B, down 0.84% from $13.2B the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Jensen Investment Management withdrew a net $677M in Q1 2024, closing 2 positions and reducing 48 holdings. Its most notable exit was Pfizer, an estimated $339M position sold in full.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 39% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jensen Investment Management opened a new position in Zoetis worth $266M.
- Jensen Investment Management's largest Q1 2024 buy was Zoetis: 1,570,349 shares worth $266M.
- Jensen Investment Management added most to Marsh in Q1 2024, an estimated $47.2M increase.
- Jensen Investment Management's biggest Q1 2024 reduction was PepsiCo, cutting an estimated $289M.
- Jensen Investment Management fully exited Pfizer in Q1 2024, selling an estimated $339M.
- Jensen Investment Management's ten largest holdings make up 55% of its $13.1B portfolio in Q1 2024.
- Jensen Investment Management opened 4 new positions and closed 2 in Q1 2024.
- Jensen Investment Management's portfolio value fell 0.84% quarter-over-quarter to $13.1B.
Based on Jensen Investment Management's 13F filing for Q1 2024, filed 7 May 2024.